Converge Bio: Funding, Investors & Team (Sep 2026)
Converge Bio is at the forefront of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) specifically trained on biological languages.
Converge Bio has raised $30.5M across 2 funding rounds on record, the most recent a Series A of $25.0M announced in Jan 2026.
That round is above the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Converge Bio Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Converge Bio Funding Rounds
Converge Bio raised $5.5M in a Seed announced in Nov 2024.
1.2 years later, a Series A of $25.0M was announced in Jan 2026.
Converge Bio Founders and Leadership Team
Contact details for the Converge Bio team: 2 of 2 have an email address on file.
Start 14-day free trial →Converge Bio Funding Compared to Other Artificial Intelligence Startups
Converge Bio's latest round of $25.0M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Converge Bio in Artificial Intelligence and Wilmington
Companies Similar to Converge Bio
Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…
Instinct is an artificial intelligence startup developing AI technology.
Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…
Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…
Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…
Gatik, a new company, is creating technology for self-driving trucks that are used for short-distance…
Generalist AI develops AI and robotics technologies focused on enabling robots to perform physical tasks in…
Quintessent is a start-up in Santa Barbara that specializes in bringing quantum dot-based lasers and photonic…
Contact: Cardiosense is building a physiological waveform data platform that leverages novel multi-modal…
Thunder is a Cloud computing to democratize access to GPUs and solve the ongoing GPU shortage. Decentralized…
Deepgram helps enterprises unlock the potential of their audio data with custom trained speech recognition…
Converge Bio Funding FAQs
What does Converge Bio do?
Converge Bio is at the forefront of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) specifically trained on biological languages.
How much funding has Converge Bio raised?
Converge Bio has raised $30.5M across 2 rounds on record. The most recent is a Series A of $25.0M announced in Jan 2026.
When did Converge Bio last raise funding?
Converge Bio's most recent funding round on record is a Series A of $25.0M, announced in Jan 2026.
Who founded Converge Bio?
FundedIQ lists Dov Gertz (Founder), Oded Kalev (Founder) at Converge Bio.
Where is Converge Bio headquartered?
Converge Bio is based in Wilmington, Delaware, United States.
How many employees does Converge Bio have?
Converge Bio is in the 11-50 employee band.
How does Converge Bio's funding compare to other Artificial Intelligence startups?
Converge Bio's latest round of $25.0M is above the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.
About FundedIQ's Converge Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Converge Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.